Icosphere Biosciences

Icosphere Biosciences is a biotechnology company developing manufacturing technology for high-capacity gene therapy vectors.

Its platform enables scalable, high-yield, contamination-free production of high capacity adenoviral vectors capable of carrying substantially more genetic material than conventional viral vectors, addressing a key limitation in delivering large genes or multiple gene-editing components.

The technology targets diseases that are currently difficult to treat with existing vector systems, including Duchenne Muscular Dystrophy and Stargardt's Disease.